These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15319806)

  • 1. Experimental approaches to evaluate endothelin-A receptor antagonists.
    Vatter H; Zimmermann M; Seifert V; Schilling L
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):277-86. PubMed ID: 15319806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm.
    Cirak B; Kiymaz N; Ari HH; Ugras S
    Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor antagonists and cerebral vasospasm.
    Zimmermann M; Seifert V
    Clin Auton Res; 2004 Jun; 14(3):143-5. PubMed ID: 15241641
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
    Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
    Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm.
    Vatter H; Konczalla J; Weidauer S; Preibisch C; Raabe A; Zimmermann M; Seifert V
    Neurosurgery; 2007 Jun; 60(6):1100-8; discussion 1108-9. PubMed ID: 17538385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage.
    Xie A; Aihara Y; Bouryi VA; Nikitina E; Jahromi BS; Zhang ZD; Takahashi M; Macdonald RL
    J Cereb Blood Flow Metab; 2007 Oct; 27(10):1692-701. PubMed ID: 17392694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm].
    Fandino J; Fathi AR; Graupner T; Jacob S; Landolt H
    Neurocirugia (Astur); 2007 Feb; 18(1):16-27. PubMed ID: 17393042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin receptor antagonists and cerebral vasospasm: an update.
    Chow M; Dumont AS; Kassell NF
    Neurosurgery; 2002 Dec; 51(6):1333-41; discussion 1342. PubMed ID: 12445337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvasospasms After Experimental Subarachnoid Hemorrhage Do Not Depend on Endothelin A Receptors.
    Liu H; Dienel A; Schöller K; Schwarzmaier SM; Nehrkorn K; Plesnila N; Terpolilli NA
    Stroke; 2018 Mar; 49(3):693-699. PubMed ID: 29438081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin receptor antagonists in preclinical models of pulmonary hypertension.
    Pullamsetti SS; Schermuly RT
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():3-13. PubMed ID: 19335741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?
    Zemke D; Farooq MU; Mohammed Yahia A; Majid A
    Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17beta-estradiol inhibits endothelin-1 production and attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.
    Lin CL; Dumont AS; Wu SC; Wang CJ; Howng SL; Huang YF; Wong WY; Kassell NF; Jeng AY; Kwan AL
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1054-7. PubMed ID: 16741048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin receptor antagonists.
    Motte S; McEntee K; Naeije R
    Pharmacol Ther; 2006 Jun; 110(3):386-414. PubMed ID: 16219361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage.
    Suhardja A
    Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):110-6; quiz 2 p following 116. PubMed ID: 16265315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelins and the cerebral circulation.
    Salom JB; Torregrosa G; Alborch E
    Cerebrovasc Brain Metab Rev; 1995; 7(2):131-52. PubMed ID: 7669492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
    Lu H; Shi JX; Chen HL; Hang CH; Wang HD; Yin HX
    Brain Res; 2009 Mar; 1262():73-80. PubMed ID: 19401162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.
    Zhang Y; Belayev L; Zhao W; Irving EA; Busto R; Ginsberg MD
    Brain Res; 2005 May; 1045(1-2):150-6. PubMed ID: 15910773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug.
    Battistini B; Berthiaume N; Kelland NF; Webb DJ; Kohan DE
    Exp Biol Med (Maywood); 2006 Jun; 231(6):653-95. PubMed ID: 16740981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat.
    Beg SA; Hansen-Schwartz JA; Vikman PJ; Xu CB; Edvinsson LI
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):846-56. PubMed ID: 16251886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.